Search results for “Pediatric cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 68 patents, we discovered top 15 key players by total patent application. Loxo Oncology, Inc., Aventis Pharma, Pfizer Inc. are dominant in this area. They take 66.18% of the total patent filing.
Loxo Oncology, Inc.
New York, United States
Patent: 22
Aventis Pharma
Belgium
Patent: 17
Pfizer Inc.
New York, United States
Patent: 4
Replimune Ltd.
United Kingdom
Patent: 4
Eli Lilly & Co.
Indiana, United States
Patent: 3
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 2
Aventis Pharma SARL
France
Patent: 2
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 1
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 31 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Loxo Oncology, Inc., Pfizer Inc., Replimune Ltd. take 51.61% of patent filing during this period.
Loxo Oncology, Inc.
New York, United States
Patent: 8
Pfizer Inc.
New York, United States
Patent: 4
Replimune Ltd.
United Kingdom
Patent: 4
Eli Lilly & Co.
Indiana, United States
Patent: 3
Yonsei Industry-Academic Cooperation Foundation
South Korea
Patent: 3
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Stichting Radboud universitair medisch centrum
Netherlands
Patent: 2
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 1
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 1
Stichting Katholieke Universiteit
Gelderland, Netherlands
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 31 patents in last 5 years, we discover 9 new entrants. Pfizer Inc., Replimune Ltd., Eli Lilly & Co. are the most active new entrants in this area.
Pfizer Inc.
New York, United States
Patent: 4
Replimune Ltd.
United Kingdom
Patent: 4
Eli Lilly & Co.
Indiana, United States
Patent: 3
Yonsei Industry-Academic Cooperation Foundation
South Korea
Patent: 3
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Stichting Radboud universitair medisch centrum
Netherlands
Patent: 2
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 1
Stichting Katholieke Universiteit
Gelderland, Netherlands
Patent: 1
ARIAD Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: